Perfect Corp.

PERFNYSEUSD
1.66 USD
0.02 (1.19%)🟢LIVE (AS OF 10:50 AM EDT)
🟢Market: OPEN
Open?$1.70
High?$1.70
Low?$1.66
Prev. Close?$1.68
Volume?51.5K
Avg. Volume?N/A
VWAP?$1.67
Bid / Ask
Bid?$1.66 × 1.9K
Ask?$1.66 × 100
Spread?$0.00
Midpoint?$1.66
Valuation & Ratios
Market Cap?169.1M
Shares Out?85.1M
Float?27.0M
Float %?31.7%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A

Shares of Perfect Corp. (PERF) are trading at $1.66. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9 and a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.
Employees
353
Market Cap
169.1M
Industry
N/A
Listed
2022-10-31
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
68
Momentum?
50
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?2.91Safe
Confidence?23%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.05%Low
Short Interest?13.1K
Days to Cover?1.0
Free Float27.0M
Avg Daily Volume91.4K
Settlement Date2026-05-15